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A B S T R A C T
Spinocerebellar ataxia type-1 (SCA1) is caused by an abnormally expanded polyglutamine (polyQ) tract in
ataxin-1. These expansions are responsible for protein misfolding and self-assembly into intranuclear inclusion
bodies (IIBs) that are somehow linked to neuronal death. However, owing to lack of a suitable cellular model, the
downstream consequences of IIB formation are yet to be resolved. Here, we describe a nuclear protein ag-
gregation model of pathogenic human ataxin-1 and characterize IIB effects. Using an inducible Sleeping Beauty
transposon system, we overexpressed the ATXN1(Q82) gene in human mesenchymal stem cells that are resistant
to the early cytotoxic effects caused by the expression of the mutant protein. We characterized the structure and
the protein composition of insoluble polyQ IIBs which gradually occupy the nuclei and are responsible for the
generation of reactive oxygen species. In response to their formation, our transcriptome analysis reveals a
cerebellum-specific perturbed protein interaction network, primarily affecting protein synthesis. We propose
that insoluble polyQ IIBs cause oxidative and nucleolar stress and affect the assembly of the ribosome by cap-
turing or down-regulating essential components. The inducible cell system can be utilized to decipher the cel-
lular consequences of polyQ protein aggregation. Our strategy provides a broadly applicable methodology for
studying polyQ diseases.
1. Introduction
Polyglutamine (polyQ) diseases are neurodegenerative disorders
caused by trinucleotide (CAG) repeat expansions in the coding region of
human genes, which result in abnormally large polyQ tracts in the
produced proteins. In spinocerebellar ataxia type-1 (SCA1), the disease
is caused by CAG expansions in the ATXN1 gene [1]. The polyQ-ex-
panded ataxin-1 (ATXN1) protein forms small oligomers and slowly
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aggregates into larger insoluble nuclear inclusions in the affected
neurons [2]. These are specifically detectable in the Purkinje cells of the
cerebellum in SCA1 patients [1]. Several lines of evidence suggest that
the deposition of large inclusions may be protective due to the se-
questration of smaller cytotoxic oligomers [3]. However, recent find-
ings indicate that insoluble inclusions might be also toxic, as they cause
quiescence and activate necrotic mechanisms in cells [4]. These events
are thought to be induced by oxidative stress and the activation of
checkpoint kinases which regulate the cell cycle [5].
PolyQ aggregates have been extensively investigated in cell-free
assays, using recombinant proteins produced in bacteria [6–8]. Studies
in yeast, murine neurons and HeLa cells overexpressing fragments of
polyQ-expanded genes provided valuable information on the structure
and interactions of pathogenic inclusions in cellular systems [9,10].
However, a reliable aggregation model is still missing. While formation
of insoluble inclusions was also observed in human induced pluripotent
stem cell (iPSC)-derived neurons [11], this phenotype cannot be easily
reproduced [12]. Therefore, novel protein aggregation models are
needed that could be readily used to characterize polyQ inclusions
generated in primary human cells.
Human mesenchymal stem cells (MSCs) have been previously used
for modeling of polyQ diseases [13]. These cells have a partial ability to
fuse with Purkinje neurons [14], suggesting that they might contribute
to the restoration of their physiological neuronal function. MSCs can be
easily modified genetically using the Sleeping Beauty (SB) transposon
system [15], a safer alternative to viral approaches [16]. Engineered
cells proliferate and stably express human transgenes for several pas-
sages [17–19]. MSCs can also model replicative senescence, a cellular
event that resembles aging and is associated with protein aggregation
[20]. Expression of aberrant, polyQ-expanded genes in human MSCs is
expected to generate suitable cellular models supporting robust, mea-
surable and reproducible pathogenic phenotypes.
In this study, we report an inducible version of a previously de-
scribed SB system [21] that can be utilized for the controlled expression
of pathogenic genes in cultured primary cells. We used this system to
overexpress polyQ-expanded ATXN1 in human MSCs and observed that
cells reproducibly accumulate intranuclear inclusion bodies (IIBs).
First, the IIBs generate cellular oxidative stress and following prolonged
induction become insoluble. Using a combination of biophysical
methods [Fourier-transform infrared spectroscopy (FTIR), atomic force
microscopy (AFM) and mass spectrometry (MS)], we characterized
their structure and protein composition. In addition, we analyzed
transcriptional changes and mechanisms of dysfunction caused by the
overexpression of mutant ATXN1 and the gradual accumulation of its
protein product. We assessed the similarity of this model with human
SCA1 cerebellum at the end-stage of the disease in terms of mechanisms
leading to disease. In particular, our data indicate that aggregation of
pathogenic ATXN1 perturbs the cellular protein synthesis machinery in
a cerebellar protein-protein interaction (PPI) network. The potential
implications of these results for the homeostasis of cerebellar neurons
are discussed.
2. Materials and methods
2.1. Construction of Tet-On Sleeping Beauty transposon plasmids
For the generation of a pT2-CMV/TetO2-EYFP-GW transposon
plasmid, the CMV promoter was excised by HindIII-NheI digestion from
a pT2-CMV-EYFP-GW plasmid [21] and replaced by a CMV/TetO2
promoter. ATXN1(Q30) (wild-type ATXN1; GeneID: 6310) or (Q82)
cDNA was shuttled into pT2-CMV/TetO2-EYFP-GW plasmid by LR re-
combination, as previously described [22]. Correct recombination was
verified by BsrGI restriction digestion.
An expression cassette encoding the SV40 promoter, β-globin in-
tron, Tet-repressor (TetR) and bGH polyA signal flanked by SpeI re-
striction sites was synthesized and cloned into a pU57C plasmid. The
cassette was subcloned by SpeI digestion into the MCS of a pT2-HB
plasmid resulting in the generation of a pT2-TetR plasmid. Then, an
expression cassette encoding the SV40 promoter, neomycin resistance
gene (neoR) and SV40 polyA site was excised by HindIII from a pT2-
neoR plasmid and inserted into the pT2-TetR plasmid, resulting in the
generation of a bicistronic pT2-TetR-neoR transposon. The orientation
of TetR and neoR expression cassettes was verified by EcoRV digestion.
Plasmid isolation was performed using a DNA plasmid purification kit
(Macherey-Nagel).
2.2. MSC and neural precursor cell (NPC) culture
Isolation and characterization of human MSCs have been previously
described [17,18]. Cells were cultured and expanded ex-vivo using
Dulbecco's modified Eagle medium (DMEM) supplemented with 10%
fetal bovine serum, penicillin (100 IU/mL) and streptomycin (100 μg/
mL). NPCs were obtained from healthy human iPSCs as previously
described [23]. Cells were seeded on Matrigel-coated plates and cul-
tured in DMEM-F12/NeuroCult 1:1 supplemented with 1:200 N2 sup-
plement, 1:100 B27 supplement lacking vitamin A, 3 μM CHIR 99021,
0.5 μM purmorphamine, 150 μM ascorbic acid (Sigma-Aldrich) and 1%
penicillin/streptomycin/glutamine [24].
2.3. Generation of stable cell lines
MSCs at passage 5 or NPCs at passage 9 were transfected with a
mixture of SB100X/pT2 plasmids using Xfect reagent (Clontech), ac-
cording to manufacturer's instructions. Briefly, 2 × 105 cells were
seeded in a 6-well tissue culture plate. The next day, cells were trans-
fected with 5 μg of total plasmid DNA encoding SB100X transposase
and pT2 plasmids (1:9 ratio). The ratio of pT2-TetO2-YFP-ATXN1(Q30)
or (Q82) and pT2-TetR-neoR transposon plasmids was 5:1. For the
generation of MSCs stably producing Venus, a pT2-GAGGS-Venus-neoR
transposon plasmid was used. Transfected cells were selected at day 7
post-transfection with 100 μg/mL G418 and expanded in the presence
of the antibiotic. For transgene induction, fresh doxycycline (Dox)
(2 μg/mL) was added every 48hrs in the culture medium.
2.4. Immunofluorescence
Tet-On YFP-ATXN1(Q82) MSCs or NPCs were cultured in the pre-
sence or absence of doxycycline in CELLview glass bottom plates
(Greiner Bio One). Then, cells were fixed with 4% paraformaldehyde
(PFA) in PBS and permeabilized with 0.1% Triton-X 100 PBS before
mounting with DAPI ProLong Gold antifade reagent (ThermoFisher).
Cells were visualized in an Axiovert microscope equipped with an HBO
50 mercury lamp and reflectors with fluorescence filter sets. Image
acquisition was performed with the Fluorescence Lite software module
of AxioVision LE (Carl Zeiss).
2.5. Flow cytometry
For quantification of transgene expression, Tet-On YFP-
ATXN1(Q82) MSCs were measured in a Cytomics FC500 flow cytometer
(Beckman Coulter) using the CXP2.2 software. For phenotypic char-
acterization, 1 × 106 cells were stained with antibodies against he-
mopoietic (CD34, 45) or mesenchymal (CD29, 73, 90 and CD105) stem
cell markers. Unstained cells or cells stained with IgG isotype antibodies
were used as negative controls.
2.6. Immunoblotting
MSCs (5 × 105) were lysed in 1% SDS PBS containing protease
inhibitors (Calbiochem) and benzonase (Novagen). Cell extracts were
analyzed in an 8% SDS-PAGE. Ectopic expression of YFP-ATXN1(Q30)
or (Q82) was validated by Western blotting with the polyclonal anti-
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ATXN1 SA4645 antibody [22] or anti-GFP antibody (MAB2510, Milli-
pore). β-actin was detected with mouse monoclonal anti-β-actin anti-
body (sc-47778, Santa Cruz). After incubation with an appropriate al-
kaline-phosphatase conjugated secondary antibody, proteins were
detected with NBT-BCIP (Applichem).
2.7. Filter retardation assay
Insoluble protein inclusions were quantified using a filter retarda-
tion assay [25]. Cell extracts of Tet-On YFP-ATXN1(Q30) or (Q82)
MSCs (150 μg total protein) were mixed with equal volumes of 4% SDS
and 100 mM DTT and heated at 95 °C for 5 min. Samples were diluted
with 100 μl 0.2% SDS and filtered through a 0.2 μm cellulose acetate
membrane. SDS-resistant inclusions retained on the membrane were
detected using the polyclonal anti-ATXN1 SA4645 antibody (1:1000)
[22].
2.8. FTIR spectroscopy
Tet-On YFP-ATXN1(Q82) MSCs were cultured on MirrIR low-e-glass
slides (Kevley Technologies, USA) washed with PBS and air dried. The
spectra were taken using a Renishaw-Smiths micro Raman-FTIR mi-
croscope (Smiths-IlluminatIR, Smiths Detection, Hertfordshire, UK) and
an ARO microscope lens (smithsARO 15x/N.A.88) at a range of
600–4000 cm−1 wavenumbers with 100 measurements for the back-
ground spectrum and 300 for the sample spectrum with a 4 cm−1 re-
solution. The low-e glass slide was placed on an automated holder and
exposed to the instrument hood-controlled temperature and humidity
environment of 22 °C and 37%, respectively. Background and sample
absorption spectra were taken at a 100 μm diameter circular region.
The sample absorption spectrum was calculated after background
subtraction using the SynchronizIR software (Soft Imaging System
GmbH, Germany). The second derivative spectra were obtained by a 5-
point Savitzky-Golay algorithm of the smoothed spectrum (11-point
binomial) using the GRAMS/32 software (Galactic Industries
Corporation, Salem, NH, USA), according to relative processing [26].
2.9. Cytotoxicity assay
Tet-On YFP-ATXN1(Q82) MSCs were cultured in 96-well tissue
culture plates (2 × 104 per well). Equal volume of Caspase 3/7 Glo
substrate (Promega) was added in each well and luminescence was
measured in a Victor3 multilabel plate reader (PerkinElmer). Each ex-
periment was performed in triplicate.
2.10. Detection of reactive oxygen species (ROS)
2′7′-Dichlorodihydrofluorescein diacetate (H2DCFDA)
(ThermoFischer) was used for detection of ROS. Tet-On YFP-
ATXN1(Q82) were resuspended in PBS with or without the dye at a
final concentration of 10 μM (loading buffer) and incubated at 37 °C for
30 min. The loading buffer was removed, cells were resuspended in
prewarmed complete medium and further incubated at 37 °C for 5 min.
The absorption and emission of the oxidation product were measured at
493 and 520 nm, respectively. Each experiment was performed in tri-
plicate.
2.11. Proteasome peptidase assay
Chymotrypsin-like (CT-L) proteasome activity was assayed in pro-
tein extracts with the hydrolysis of a specific fluorogenic peptide,
namely LLVY-AMC, at 37 °C for 30 min, as previously described [27].
Proteasome activity was determined as the difference between the total
activity in protein extracts and the remaining activity in the presence of
20 μM MG132. Fluorescence was measured using a VersaFluor fluor-
escence spectrophotometer (Bio-Rad). Protein concentrations were
determined using the Bradford method with bovine serum albumin as
standard.
2.12. Preparation of samples for AFM
Cells were either kept in culture medium or fixed with 4% PFA PBS
before observation. For imaging of nuclei, Tet-On YFP-ATXN1(Q82)
MSCs were treated as previously described [28]. In brief, AFM images
of nuclei were obtained by cell lysis in 0.25% NP-40 hypotonic Tris-HCl
pH 7.4 buffer followed by fixation. For observation of polyQ inclusions,
cells were lysed in 0.1% SDS PBS and purified inclusions attached to the
plastic surface were immersed in PBS.
2.13. AFM imaging and mechanical characterization of nuclear content
Hybrid mode imaging, contact mode and Young's modulus mapping
were performed using either Bruker Dimension FastScan (Bruker Nano
Surfaces) AFM or JPK NanoWizard 3 (JPK). Bruker SCANASYST-FLUID
+ and SNL-10 A and B silicon nitride cantilevers equipped with silicon
tip (both from Bruker Nano Surfaces) were used for imaging. Sensitivity
and cantilever spring constant were calibrated by the routine procedure
recommended by the instrument producer.
Hybrid mode imaging (Bruker QNM mode) with SCANAS-
YST-FLUID + probe was employed to record semi-quantitative images
of isolated nucleus in PBS buffer. Images covering an area of 15 × 15
μm2 and 2.5 × 2.5 μm2 area (1500 × 1500 px2 resolution) were re-
corded with a set point of 0.75 nN and lifting height of 150 nm, (Z-piezo
range 0.75 μm and 0.35 μm, respectively). Images covering the whole
nucleus (20 × 20 μm2, 1024 × 1024 px2 resolution) as well as the
detailed view of 5 × 5 and 2 × 2 μm2 were recorded by JPK
Quantitative Imaging mode (hybrid mode) with a set point of 0.35 nN
and lifting height of 90 nm (Z-piezo range was shortened to 3.0 μm).
Cells fixed on a standard microscopic glass slide were visualized by
constant force contact mode (JPK NanoWizard 3), when the Bruker
SNL-10A cantilever was used. Set-point equal to 5.0 nN, feedback set-
ting iGain = 50.0 Hz and PGain = 0.001 were the operating para-
meters for capturing images of 50 × 50, 25 × 25 and 10 × 10 μm2
(2048 × 2048 px2).
For mapping of Young's modulus of living cells a previously pub-
lished procedure [29,30] was adopted. Briefly, Bruker SNL-10B probe
was used to record 64 × 64 maps of force-distance curves (set-point
1 nN, Z-length 15 μm, time per curve 0.5 s). The recorded force-distance
(FD) curves were fitted with the Bilodeau modification of the Hertzian
model. Final post-processing and editing of the images and stiffness
maps was performed using the Gwyddion software ver. 2.44 [31].
2.14. Force-distance curves post-processing
Force mapping provides a network of force-distance curves, mea-
suring the dependence of the tip-sample interaction force on the tip
height above the surface. The absolute value of Young's modulus can be
determined by fitting the FD curve to the modified Hertzian-Sneddon
equation:
=F Etan( ) 2
(1 )2
where F is the measured force, E is the Young's modulus, ν is the
Poisson's ratio (0.5 for incompressible materials), δ is the tip-sample
separation (obtained by correction of the cantilever height to its
bending) and α is the half-angle to face of pyramidal tip (reflects the tip
geometry). The data processing module of the JPK software was used to
process the maps of FD curves. The resulting Young's modulus maps
were exported in order to be post-processed using the Gwyddion soft-
ware. Data masking and final export of stiffness maps were performed
also using the Gwyddion software.
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2.15. Mass spectrometry
For proteomic analysis of insoluble polyQ inclusions, Tet-On YFP-
ATXN1(Q82) MSCs at D10 were lysed in 0.1% SDS PBS. Intact fluor-
escent polyQ inclusions were sorted from cell extracts in a BD FACSAria
IIu instrument (BD Biosciences) after doublet exclusion and using an
unstained control sample to exclude possible autofluorescence. Protein
samples were processed by the filter-aided sample preparation (FASP)
method [32]. Proteins were alkylated, digested by trypsin on filter unit
membrane and resulting peptides were eluted by ammonium bicarbo-
nate buffer. The peptide mixture was dried under vacuum and trans-
ferred using peptide extraction procedure to TPX vial. LC-MS/MS
analysis was done using the RSLCnano system (Thermo Fisher Scien-
tific) on-line connected to Impact II Ultra-High Resolution Qq-Time-Of-
Flight mass spectrometer (Bruker). The analytical column outlet was
directly linked to the CaptiveSpray nanoBooster ion source (Bruker ).
MS and MS/MS spectra were acquired in a data-dependent strategy
with 3 s long cycle time.
For quantitative mass spectrometry, technical triplicates of Tet-On
YFP-ATXN1(Q82) MSCs at D10 or D0 were lysed in SDT buffer. LC-MS/
MS analysis of peptide mixture was done using RSLCnano system
(Thermo Fisher Scientific) on-line connected to Orbitrap Q-Exactive HF
X system (Thermo Fisher Scientific). The analytical column outlet was
directly linked to the Digital PicoView 550 (New Objective) ion source.
ABIRD (Active Background Ion Reduction Device, ESI Source Solutions)
was installed. MS data were acquired in a data-dependent strategy se-
lecting up to top 20 precursors.
The analysis of the mass spectrometric data was carried out using
Maxquant (version 1.6.3.3) with Andromeda search engine utilization.
Search was done against the UniprotKB Human (version 20180912) and
Maxquant's contamination databases (downloaded with given version).
Mass tolerances for peptides and MS/MS fragments were 4.5–10 ppm
and 0.05 Da, respectively. Oxidation of methionine, deamidation (N, Q)
and protein N-terminal acetylation as optional modifications, carba-
midomethylation (C) as fixed modification and two enzyme miss clea-
vages were set for search. Peptides and proteins with false discovery
rate (FDR; q-value) < 1% were considered. Maxquant label free
quantification algorithm (MaxLFQ) was applied for global data nor-
malization [33] (minimal ratio count 1). MQ protein group list was
processed via KNIME Analytics Platform (v. 3.7.1). Results have been
deposited in the PRIDE Archive (https://www.ebi.ac.uk/pride/archive)
under accession number PXD012709.
2.16. RNA-sequencing
Total RNA was extracted from Tet-On YFP-ATXN1(Q82) MSCs using
the AllPrep DNA/RNA/miRNA Universal Kit (QIAGEN), according to
manufacturer's instructions. For library preparation, mRNA was en-
riched from 250 ng total RNA using the NEBNext® Poly(A) mRNA
Magnetic Isolation Module (New England Biolabs), according to man-
ufacturer's protocol. Sequencing libraries were prepared from mRNA
using SENSE Total RNA-seq Library Prep Kit (Lexogen), according to
manufacturer's protocol. Single-end 75 bp sequencing was performed in
a NextSeq 500 instrument (Illumina). In average, more than 30 million
reads per time-point were obtained.
Post-mortem human cerebellum from a 74-year-old female SCA1
patient and an age-/sex-matched healthy individual (Sample ID: A136/
02 and A158/14, respectively) were obtained from the MRC London
Neurodegenerative Diseases Brain Bank. Total RNA was extracted from
frozen samples using the Direct-zol RNA Kit (Zymo Research). An ali-
quot of total RNA was loaded on Total RNA Pico Chip and measured for
its integrity using Bionalyzer 2100 (Agilent Technologies). Sequencing
libraries were prepared using KAPA RNA HyperPrep with Ryboerase
kit, according to manufacturer's instructions (Roche). High throughput
single-indexed, paired-end 75 bp sequencing was performed in a HiSeq
4000 instrument (Illumina). RNA-seq data have been deposited in the
ArrayExpress database at EMBL-EBI (www.ebi.ac.uk/arrayexpress)
under accession numbers E-MTAB-7713 and E-MTAB-7714.
2.17. Data analysis and visualization of RNA-seq data
The quality control was performed based on the FastQC software
(Babraham Institute, Cambridge, UK). Samples with a low number of
raw reads (less than 10 million per sample) were excluded from
downstream analysis. Reads were trimmed and filtered using Trim
Galore! and consequently aligned against the UCSC hg19 reference
genome using the HΙSAT2 protocol [34]. Overall alignment rate for all
samples ranged between 89% and 93%. Transcriptome assembly was
performed using StringTie and differential expression calculation was
performed using Ballgown. Gene expression levels were normalized to
Fragments Per Kilobase of transcript per Million (FPKM).
Subsequent data analysis was carried out in the R environment. T-
test was applied to compare FPKM levels between the two different
groups. Hierarchical clustering analysis was performed applying the R
package “gplots” and FPKMs were normalized to z-score. The agglom-
erative hierarchical clustering was performed using the Euclidean dis-
tance metric and the complete agglomeration method. To compute the
principal components (PCs), the prcomp function was applied. Gene set
enrichment analysis (GSEA) was calculated using the clusterProfiler R
package [35]. Gene Ontology (GO) and Pathway enrichment analyses
were performed using the online tool Enrichr where KEGG and PAN-
THER pathways were examined [36]. Venny 2.1 (BioinfoGP,
CNB–CSIC, http://bioinfogp.cnb.csic.es/tools/venny/index.html) was
utilized to overlap the differentially expressed genes from different
comparisons.
2.18. Construction of a PPI network
The PPI network in which the products of differentially expressed
(DE) genes participate was constructed using release 2 of the Human
Integrated Protein-Protein Interaction rEference (HIPPIE) [37]. Only
cerebellum-specific interactions with HIPPIE confidence scores of at
least 0.63 (median of all scores in the database) were considered, which
resulted in a network of 516 proteins.
2.19. Statistical analysis
Statistical analysis was performed using the GraphPad Prism soft-
ware (San Diego, USA). All cell-based assays were performed in tripli-
cates and results are shown as mean ± SEM calculated by a T-test. For
AFM measurement of cell stiffness, a one-way ANOVA with Bonferroni
post-hoc test was used.
To determine if the size of the largest connected component (LCC) of
the constructed PPI network (328 proteins) was greater than expected
by chance, it was compared with a distribution of LCC sizes using a z-
test. This distribution resulted from randomly sampling 516 proteins
1,000 times from the complete cerebellum-specific PPI network. A z-
test was also employed to determine if the number of DE genes,
common to cells and the SCA1 patient and also present in the PPI
network, was significantly larger than expected by chance. Specifically,
we randomly sampled 185 genes from the 3,923 SCA1-differentially-
expressed pool 1,000 times and intersected the sample with the 328
members of the PPI LCC. Then, we checked whether 109 (the actual size
of the intersection between the 185 SCA1-DE genes and the LCC) was
significantly greater than the constructed random distribution.
Differences in protein levels of the network were investigated by
LIMMA test. P-values were adjusted with the Benjamini-Hochberg
method.
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3. Results
3.1. Inducible Sleeping Beauty transposon system to express ATXN1
variants
In order to develop a stable ATXN1 expression model, an inducible
Tet-On SB transposon system was generated. The system consists of two
pT2-based expression plasmids, a Tet-On YFP-tagged Gateway desti-
nation plasmid, in which ATXN1(Q82) was shuttled [resulting in YFP-
ATXN1(Q82)], and a TetR-neoR bicistronic transposon plasmid en-
coding for the TetR protein and the neomycin resistance gene
(Fig. 1A–B). Using the hyperactive SB100X transposase [15], a stable
expression cell line was generated in human MSCs.
Tet-On YFP-ATXN1(Q82) MSCs displayed no fluorescent signal in
the absence of the inducer Dox (D0), whereas inducing the cells for 24 h
(D1) resulted in readily detectable fluorescent YFP-ATXN1(Q82) signal
(Fig. 1C). Following quantification by flow cytometry, cells at D1 were
84.1% positive for YFP fluorescence signal (Figs. 1D) and 95% after
48 h (D2) of induction. The induced cells produced high levels of YFP-
ATXN1(Q82) after 48hrs (D2). An identical molecular weight band
(~130 kDa) was also detectable with an anti-GFP antibody (Fig. 1E),
corresponding to the exogenous YFP-tagged polyQ-expanded protein,
and not the endogenous ATXN1.
We also investigated whether Tet-On YFP-ATXN1(Q82) MSCs retain
their mesenchymal phenotype. As indicated by flow cytometry, unin-
duced/D0 cells were negative for Cluster of Differentiation (CD) mar-
kers of the hematopoietic lineage (CD34 and CD45). In contrast, they
were >95% double positive for CD markers of the mesenchymal
lineage (CD29, CD73, CD90 and CD105) (Supplementary Fig. 1). This
indicates that SB-mediated genetic modification did not affect the me-
senchymal properties of the stable lines.
3.2. The pathogenic ATXN1 forms specific annular IIBs in MSCs
Next, we studied the morphology of YFP-ATXN1(Q82) IIBs at dif-
ferent time-points post induction. Cells accumulated small inclusions at
D2 that increased in size and partially fused by day 5 (D5). At this point,
inclusions consisted of distinct subdomains and seemed to expand
around a brighter central core. At day 10 (D10), IIBs adopted an an-
nular structure and dramatically increased in size, occupying most of
the nucleus (Fig. 2A). Annular IIBs were also formed in neural pro-
genitor cells (NPCs) derived from healthy iPSCs (Supplementary
Fig. 2A). However, only a few of them contained fluorescent inclusions
at D10 post induction, suggesting that iPSC-derived NPCs, by contrast
to MSCs, may efficiently remove small inclusions or suppress long-term
production of the pathogenic ATXN1. Therefore, further experiments
were performed using genetically-modified MSCs.
In order to investigate whether polyQ-expansions in ATXN1 are
responsible for the annular structure of IIBs, we also generated an in-
ducible control MSC line, producing the wild-type protein YFP-
ATXN1(Q30). YFP-ATXN1(Q30) formed spherical IIBs which also in-
creased in size upon prolonged induction with Dox (Supplementary
Fig. 2B). However, in contrast to mutant ATXN1, these IIBs did not
adopt an annular shape at D10. Therefore, ATXN1 with an expanded
polyQ tract specifically forms annular IIBs in MSCs.
To analyze the solubility of ATXN1 proteins, equal amounts of Tet-
On YFP-ATXN1(Q30) as well as YFP-ATXN1(Q82) MSC extracts, were
analyzed by SDS-PAGE. While, soluble YFP-ATXN1(Q30) and YFP-
Fig. 1. Generation of Tet-On YFP-ATXN1(Q82) MSCs using a novel inducible SB transposon system. (A) Schematic overview of the Tet-On principle. In the absence of
tetracycline, TetR protein dimers bind to the CMV/TetO2 promoter and suppress transgene expression. In the presence of tetracycline, TetR adopts a different
conformation and loses its affinity for the CMV/TetO2 promoter allowing transgene expression. (B) Components of the Tet-On SB transposon system. The system is
comprised of two pT2-based plasmids, a Tet-On Gateway compatible and a bicistronic TetR-neoR transposon. (C) Fluorescence microscopy of Tet-On YFP-
ATXN1(Q82) MSCs in the absence (D0, left) or presence (D1, right) of Dox (scale bar = 25 μm). (D) Flow cytometry (histogram plot) of uninduced (blue color) and
induced (green color) cells. (E) Immunoblot detection of transgene expression in extracts of uninduced and induced cells using anti-ATXN1 or anti-GFP antibodies. β-
actin was used as a loading control. . (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)
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ATXN1(Q82) were detected at the expected molecular weight at D2, D5
and D10 (Supplementary Fig. 2C and 2B, lower band), a fraction of YFP-
ATXN1(Q82) appeared in a higher molecular weight region of the gel in
extracts from D5 and D10 cells. These protein species failed to enter the
resolving gel or accumulated at the bottom of the well of the loading gel
(Fig. 2B). Finally, we examined whether YFP-ATXN1(Q82) IIBs are
detectable in a filter retardation assay. This method allows quantifica-
tion of large, insoluble SDS-stable protein inclusions [25]. Pathogenic
ATXN1(Q82) readily formed SDS-stable inclusions at D10 (Fig. 2C),
whereas no such inclusions were immunodetected in MSCs inducibly
producing YFP-ATXN1(Q30) (Supplementary Fig. 2D). Taken together,
these data indicate that mutant ATXN1 forms insoluble IIBs in MSCs
with a potential pathogenic conformation after prolonged induction.
3.3. ATXN1(Q82) IIBs are enriched in coiled-coils and β-sheets
We then sought to investigate whether pathogenic ATXN1 adopts a
β-sheet conformation in IIBs. To do so, we determined the nominal FTIR
absorption spectrum of Tet-On YFP-ATXN1(Q82) MSCs at D10 and
observed typical peaks for the main biological macromolecules
(Supplementary Fig. 3). Proteins were detected by two different ab-
sorption peaks corresponding to amide I and II signals (1400-
1800 cm−1) that are related to the C]O stretching vibration of the
peptide bond [38]. Similar absorption spectra were also obtained from
Tet-On YFP-ATXN1(Q82) MSCs at D0 or D2 (Supplementary Fig. 3).
The measurement from D0 cells was taken as background and
subtracted from the absorption spectrum of Tet-On YFP-ATXN1(Q82)
MSCs at D2 or D10. The second derivative of the corrected spectra
showed no distinct peaks in the range of amide I at D2 in YFP-
ATXN1(Q82) expressing MSCs. This indicates that these cells contain
proteins with a similar conformation to D0 MSCs. In contrast, Tet-On
YFP-ATXN1(Q82) MSCs at D10 exhibited strong peaks at 1657, 1640
and 1686 cm−1 (Supplementary Fig. 4). The distinct high-intensity
peak at 1657 cm−1 may be attributed to α-helical protein structures
[38] of YFP-ATXN1(Q82). However, the peak at 1640 cm−1 combined
with a low-intensity peak at 1685 cm−1 suggests an enrichment for
coiled-coils [39] and β-sheets [40,41] in the aggregated polyQ-ex-
panded protein.
To exclude the possibility that these peaks result from the fluor-
escent protein tag, a Venus-tagged MSC line, stably producing a fluor-
escent variant of YFP [42], was generated as a control. The absorption
spectrum of Venus MSCs (Supplementary Fig. 3) was subtracted from
the relevant spectra of Tet-On YFP-ATXN1(Q82) MSCs at D2 or D10 and
their second derivatives are illustrated in Fig. 2D. The spectrum of D10
Tet-On YFP-ATXN1(Q82) MSCs showed strong peaks at 1657, 1640 and
1686 cm−1 along with an additional low peak at 1700 cm−1. No such
peaks were observed in D2 cells. These results suggest that the detected
peaks can be attributed merely to polyQ-expanded ATXN1. Further-
more, the peaks at 1640 and 1686 cm−1 indicate that aggregated YFP-
ATXN1(Q82) is enriched in coiled-coils and intra-molecular β-sheets,
while the 1700 cm−1 peak suggests that the pathogenic protein also
forms inter-molecular β-sheets in IIBs [40,43]. This finding suggests
that the insolubility of YFP-ATXN1(Q82) IIBs (Fig. 2C) is due to the
enrichment of the number of coiled-coils, intra- and inter-molecular β-
sheets in the pathogenic protein.
3.4. Intranuclear accumulation of ATXN1(Q82) IIBs affects the mechanical
properties of MSCs
Next, we determined the biophysical properties of YFP-
ATXN1(Q82) expressing MSCs using AFM. This method provides
structural, mechanical and functional information of non-stained cells
Fig. 2. MSCs expressing YFP-ATXN1(Q82) accumulate insoluble IIBs. (A) Fluorescence microscopy of Tet-On YFP-ATXN1(Q82) MSCs at D2-D10. Nuclei are stained
with DAPI (blue color) (scale bar = 10 μm). (B–C) Immunoblots for ATXN1 in B. SDS-PAGE and C. Filter retardation assays using extracts of uninduced or induced
cells. β-actin was used as loading control. (D) Second derivative of the FTIR absorption spectrum of Tet-On YFP-ATXN1(Q82) MSCs at D2 or D10. Spectra were
corrected after subtraction of the Venus MSCs spectrum. The D10 spectrum shows a peak at 1657 cm−1 indicative of α-helix conformation and three peaks at 1640,
1686 and 1700 cm−1, corresponding to coiled-coils, intra- and inter-molecular β-sheets in ATXN1(Q82). (For interpretation of the references to color in this figure
legend, the reader is referred to the Web version of this article.)
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or molecules at high resolution under physiological conditions [44,45].
The occupied nuclear area was similar in D0 and D2 MSCs indicating
that polyQ inclusions were not detectable by AFM at these time-points.
In contrast, a significant increase of the nuclear content was observed in
D5 and D10 MSCs (Supplementary Fig. 5A). In the contact mode
images, the nuclear content appeared above the threshold (blue masked
area). Quantification of the masked area revealed an approximately 12-
fold increase in occupied nuclear surface area of D10 MSCs compared to
D0 cells (Supplementary Fig. 5B). These data illustrate that the growth
of YFP-ATXN1(Q82) IIBs can be efficiently quantified by AFM. Hybrid
mode AFM images provided a detailed visualization of the nuclear
content. Processing of force-distance curves by the surface distribution
of the slope of indentation curve, allowed us to distinguish between
natural nuclear structures (e.g. nucleoli - marked with the white arrow)
and polyQ inclusions (Fig. 3A). Overlay of AFM and fluorescence
images showed that the marked structures were non-fluorescent
(Supplementary Fig. 6) excluding the possibility that they represent
smaller polyQ protein inclusions. These images indicate that annular
IIBs compress the nucleoli (Fig. 3A), suggesting that the accumulation
of YFP-ATXN1(Q82) may interfere with their physiological function.
Mechanical properties of Tet-On YFP-ATXN1(Q82) MSCs were stu-
died using the force-volume/nanoindentation method [30,46]. The
Young's modulus (stiffness) of D0 and D10 MSCs was compared. There
was no significant difference when Young's modulus of whole cells was
compared (10.2 ± 2.8 kPa and 23 ± 15 kPa, for D0 and D10 cells,
respectively), possibly due to the small occupied area of protein in-
clusions. However, a significant difference was observed when only the
area containing IIBs was compared with the stiffness of an uninduced
cell (10.2 ± 2.8 kPa and 36 ± 19 kPa for D0 and D10 cells, respec-
tively, p-value < 0.01) (Supplementary Figs. 7A–B). Similarly, the to-
pography of these cells was compared. Using the set point height
technique, YFP-ATXN1(Q82) IIBs were efficiently detected only in D10
MSCs (Supplementary Fig. 7C).
3.5. Accumulation of large ATXN1(Q82) IIBs is an irreversible process
We then investigated whether polyQ inclusions are cytotoxic.
Activated caspase 3/7 was measured in Tet-On YFP-ATXN1(Q82) MSCs
in the presence or absence of Dox. Induced cells showed similar levels
of caspase activity compared to uninduced cells at all time-points
(Supplementary Fig. 8). Deposition of YFP-ATXN1(Q82) IIBs does not
induce apoptosis in these cells. Nevertheless, after prolonged (10 days)
induction, Tet-On YFP-ATXN1(Q82) MSCs acquired an enlarged and
flattened phenotype typical of senescent cells. By D20, the majority of
cells lost their proliferative capacity and transited towards a growth-
arrested state. IIBs were readily visible by optical microscopy
(Supplementary Fig. 9A, white arrows); however, they did not sig-
nificantly increase in size compared to D10. Cells did not die; they ra-
ther maintained this state for up to 30 days post induction. These
findings suggest that the intranuclear accumulation of mutant ATXN1
does not result in the activation of apoptosis but rather affects the
normal cell cycle of MSCs.
Then, we tested whether aggregation of YFP-ATXN1(Q82) induces
oxidative stress in MSCs. As shown in Fig. 3B, production of the pa-
thogenic polyQ protein for 2 days resulted in a significant increase in
the levels of ROS. This effect was significantly enhanced in both D5 and
D10 cells (~7- or 5-fold higher ROS levels, respectively compared to D0
MSCs). Since oxidative stress induces alterations in the protein de-
gradation machinery, chymotrypsin-like (CT-L) activity of the protea-
some was measured. CT-L activity was enhanced in D2 cells and further
elevated at later time-points. D10 cells showed approximately 3-fold
higher proteasome activity compared to D0 MSCs (Fig. 3C). To check if
the aggregation was reversible, we asked whether removal of Dox from
induced cells would result in the clearance of polyQ inclusions. Tet-On
YFP-ATXN1Q82MSCs were induced for 10 days; they were then cul-
tured for 5 additional days in medium without Dox. Cells containing
large YFP-ATXN1(Q82) IIBs failed to dissolve them (Supplementary
Fig. 9B), indicating that aggregated polyQ proteins are resistant to
Fig. 3. Cellular effects of YFP-ATXN1(Q82) IIBs. (A) Detailed view of the cell nucleus. Cells at D0-D10 were fixed and visualized by AFM in hybrid mode
(Quantitative Imaging). White arrows indicate natural nuclear content (nucleoli). The white scale bar in the right image is equal to 20 μm. Z-scaling of all images
ranges from 85 to 190 mN/m (B–C) Percentages of (B) ROS and (C) CT-L proteasome activity in uninduced and induced Tet-On YFP-ATXN1(Q82) MSCs at D2, D5
and D10. ROS levels and CT-L activity of control cells (D0) were arbitrarily set to 100%. Error bars denote ±SEM (** p-value < 0.01, *** p-value < 0.001).
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degradation. This observation supports our finding that Tet-On YFP-
ATXN1(Q82) MSCs at D10 contain insoluble IIBs (Fig. 2C–D).
3.6. Insoluble ATXN1(Q82) IIBs recruit proteins associated with
neurodegenerative processes
Based on our finding that polyQ inclusions are insoluble in SDS
(Fig. 2C), we sought to isolate and characterize them. Intact annular
inclusions of YFP-ATXN1(Q82) at D10 were observed by fluorescence
microscopy and AFM (Supplementary Fig. 10A). A detailed view of the
inclusion surface using AFM hybrid mode indicated the presence of a
lamellar structure (Fig. 4A and C). A higher magnification also showed
the presence of pores between the layers of the inclusion (Fig. 4B). The
average height of an inclusion was 14.8 ± 5.2 nm. Stiffness measure-
ment on a 6 μm2 area of the polyQ inclusion showed the distribution of
Young's modulus with an average value of 33.6 MPa (Fig. 4A-SM).
Annular polyQ inclusions were then purified from extracts by par-
ticle sorting. Efficient isolation was validated post-sorting by flow cy-
tometry (Supplementary Fig. 10B). Proteins recruited into polyQ in-
clusions were identified by mass spectrometry (MS). In total, 303
different proteins were detected (Supplementary Table 1A) including
proteasome and ribosome subunits, ubiquitin-related enzymes and
heat-shock proteins. We identified proteins with nuclear localization
such as histones, heterogeneous nuclear ribonucleoproteins and nu-
cleophosmin, indicating the nuclear origin of the isolated inclusions.
GO enrichment analysis showed that the majority of the identified
proteins fall into two distinct clusters, neutrophil degranulation/exo-
cytosis and translation (Supplementary Table 1B) and are functionally
similar with protein components of polyQ-expanded Httex1 inclusions
(Supplementary Table 1C) [4,10,47,48]. Notably, pathway analysis
using the PANTHER database showed that the fraction of proteins re-
cruited into insoluble polyQ IIBs is significantly enriched for the terms
Parkinson's and Huntington's disease (Table 1), supporting their re-
levance for neurodegenerative disease modeling.
3.7. Partially soluble and insoluble ATXN1(Q82) IIBs generate different
transcriptional responses
ATXN1 is an RNA-binding protein participating in transcriptional
regulation [49,50]. Therefore, we investigated transcriptional changes
induced by its overexpression in MSCs. Transcriptome profiles of D0-
D10 cells were generated and compared to those of Venus MSCs. Genes
with a similar expression profile in both overexpression models
(Supplementary Fig. 11A) were excluded from downstream analysis.
This experimental setup identified 3,984 differentially expressed (DE)
genes (hereafter, ATXN1-DE) due to YFP-ATXN1(Q82) overexpression
(Supplementary Table 2). Gene Set Enrichment Analysis (GSEA) of
ATXN1-DE genes dysregulated in D2 compared to Venus MSCs
(|log2fold change| ≥ 1, p-value < 0.05) indicated that expression of
the mutant ATXN1 significantly affected genes encoding proteins with
nuclear localization (Supplementary Table 3).
Principal component analysis (PCA) indicated that D2, D5 and
D10 cells had a distinct expression profile compared to D0. D2 cells
were also distinct from D5 and D10 MSCs, which grouped closely and
shared a more common expression profile (Fig. 5A). ATXN1-DE clusters
included 611, 682 and 687 genes for D2, D5 and D10, respectively and
1040 unique genes in total. The majority of genes were down-regulated
(Fig. 5B). A total of 296 genes (28.5%) were found to be dysregulated at
all time-points compared to D0 cells. Pathway term enrichment analysis
using the KEGG database showed that these genes were enriched in
components of the ribosome or the PI3K-Akt signaling pathway (Fig. 5C
and Supplementary Table 4A).
The identity of 148 genes (14.2% of 1,040 genes) specifically dys-
regulated in D2 cells was investigated. GO Biological Process (BP) in-
dicated several genes involved in positive regulation of neuron apop-
totic process (Supplementary Table 4B). Interestingly, analysis of genes
dysregulated specifically in D5 and D10 cells (181 genes, 17.4% of the
1,040 genes) revealed a set involved in the opposite process, negative
regulation of neuron apoptotic process (Supplementary Table 4C). This
indicates that soluble YFP-ATXN1(Q82) produced in MSCs at the early
time-point (D2) has a different effect in cells than the partially insoluble
protein which forms IIBs at later time-points (D5 and D10). We also
Fig. 4. Detailed view of polyQ ATXN1 pro-
tein inclusions visualized in-situ. IIBs from
Tet-On YFP-ATXN1(Q82) at D10 were im-
mobilized on a plastic surface after lysis of
cells in 0.1% SDS PBS. Measurements were
performed in isotonic PBS by AFM hybrid
mode imaging. Closer view of different parts
of an IIB is shown below the main image in
A–C. A-SM shows the distribution of stiff-
ness over the area of image A. Inserted scale
bars and Z-scale ranges are as follows: main
image 3 μm/100 nm, (A) 1 μm/15 nm, (A-
SM) 1 μm/3–130 MPa, (B) 300 nm/30 nm
and (C) 750 nm/30 nm.
S. Laidou, et al. Redox Biology 32 (2020) 101458
8
investigated the identity of 115 genes (11.1% of the 1040 genes) ex-
clusively dysregulated in D10 cells containing insoluble IIBs. GO Cel-
lular Component (CC) analysis revealed enrichment terms for PML body
and other subnuclear structures (Supplementary Table 4D) that are
associated with response to oxidative stress [51]. This is in agreement
with our observation that production of mutant ATXN1 induces oxi-
dative stress in MSCs (Fig. 3B) and the related cell response pathways.
These data illustrate the complexity of the dynamic processes that occur
in cells expressing pathogenic ATXN1 in consecutive time-points.
Enrichment analysis using the KEGG database on the significantly
dysregulated ATXN1-DE genes at D2 indicated that up-regulated genes
participate in ECM-receptor interaction or focal adhesion, while down-
regulated genes were involved in the ribosome, DNA replication, cell
cycle and oxidative phosphorylation. Importantly, a significant number
of down-regulated genes participate in pathways related to neurode-
generative diseases, validating our polyQ protein aggregation model
(Table 2A).
Regarding cellular pathways that were affected by the accumulation
of insoluble IIBs in MSCs, we compared D10 and D2 MSCs (S11B Fig).
Up-regulated genes were enriched in functions related to protein di-
gestion and absorption and AGE-RAGE, PI3K-Akt, p53 signaling path-
ways. In contrast, down-regulated genes were involved in DNA re-
plication and cell cycle (Table 2B), consistent with our observation that
MSCs containing insoluble IIBs enter a growth-arrest phase
(Supplementary Fig. 9A).
3.8. Tet-On YFP-ATXN1(Q82) MSCs share transcriptional similarities with
human SCA1 cerebellum
Does our inducible YFP-ATXN1(Q82) MSC system share transcrip-
tional changes with a pathogenic SCA1 human cerebellum? To answer
this question, we performed RNA-seq in post-mortem cerebellar tissue
Table 1
Pathway enrichment analysis of proteins detected in insoluble polyQ IIBs.
Enrichment term Overlap p-value Genes/Proteins
Cytoskeletal regulation by Rho GTPase (P00016) 12/70 <0.0001 TUBB2B; TUBB6; ACTC1; TUBB3; TUBB; CFL1; ARPC4-TTLL3; MYH9; PFN1;
TUBB4B; MYH10; ACTG1
Integrin signaling pathway (P00034) 15/156 <0.0001 ITGB1; ARF1; ACTN1; COL12A1; FN1; ACTN4; ACTG1; COL1A1; COL3A1;
COLA2; COL6A1; FLNA; FLNB; TLN1; VCL
Parkinson's disease (P00049) 11/81 <0.0001 HSPA9; YWHAE; PSMA5; HSPA8; UCHL; HSPA5; YWHAQ; YWHAB; YWHAZ;
YWHAG; PSMA7
Huntington's disease (P00029) 10/124 <0.0001 ARF4; TUBB6; TUBB2B; ARF1; ACTC1; TUBB3; TUBB; TUBB4B; GAPDH;
ACTG1
Glycolysis (P00024) 6/17 <0.0001 TPI1; PKM; PGK1; ENO1; ALDOA; GAPDH
Top five statistically significant enriched pathway terms and overlap of identified genes/proteins with the components of the pathway. The analysis was performed
using the PANTHER database.
Fig. 5. Transcriptional changes in Tet-On YFP-AXN1(Q82) MSCs containing IIBs. (A) Principal Component Analysis (PCA) of the expression vectors of the 3,984
genes specifically dysregulated in Tet-On YFP-AXN1(Q82) MSCs in four time-points according to their PC1 and 2 coordinates. Percentages (%) indicate the pro-
portion of variance of analyzed data per axis. (B) Hierarchical clustering analysis and heatmap of ATXN1-DE genes between cells at D2, D5 or D10 vs D0 (|log2fold
change| ≥ 1 and p-value < 0.05). Each row represents one gene and each column one sample. Figure also shows the absolute numbers of up- or down-regulated
ATXN1-DE genes in each time point. (C) Venn diagram showing the overlap of ATXN1-DE genes per comparison (described in B). KEGG pathway enrichment analysis
of ATXN1-DE genes at all time points (D2-D10) is also shown.
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both from a late stage SCA1 patient diagnosed with dementia and spinal
cerebellar atrophy with polyglutamine inclusions, and from an age/sex-
matched healthy individual. This comparative approach identified
3,923 dysregulated genes in the SCA1 patient (|log2fold change| ≥ 1),
hereafter named as SCA1-DE genes (Supplementary Table 5). GSEA
showed that this dataset was enriched for genes encoding nuclear
proteins (Supplementary Table 6), similar to our findings in MSCs
overexpressing YFP-ATXN1(Q82) (Supplementary Table 3).
PolyQ protein inclusions are mainly detected in the cerebellum of
SCA1 patients [1]. We therefore compared the patient data with the
D10 ATXN1-DE genes in cells containing insoluble IIBs. The down-
regulated SCA1-DE and ATXN1-DE genes participate in several common
pathways, including cell cycle, oxidative phosphorylation or pathways
involved in RNA metabolism (e.g. ribosome, spliceosome and RNA
transport) (Table 3A). Similarly, common pathways were identified
between the up-regulated genes of the two sets. The up-regulated SCA1-
DE genes participate mainly in focal adhesion, as also observed for up-
regulated ATXN1-DE genes (Table 3B).
We also found that 27% (185/687) of the dysregulated D10 ATXN1-
DE genes were shared with the SCA1-DE gene set. As indicated by KEGG
enrichment analysis, the commonly dysregulated genes included genes
involved in the ribosomal function (Supplementary Tables 7A–B).
Collectively, these results indicate that the transcriptional changes at
end-stage human SCA1 cerebellum resemble the cellular response ob-
served in MSCs containing insoluble IIBs of the mutant ATXN1 at D10.
3.9. ATXN1(Q82) IIBs perturb the ribosomal protein interaction network
The protein inclusions in neurodegenerative diseases produce pa-
thogenic effects due to a trapping effect [52]. According to this hy-
pothesis, protein inclusions act as molecular “black-holes”, trapping
proteins along with their downstream interactors. We sought to model
this scenario by investigating the PPI network of the ATXN1-DE pro-
teins.
To gain insights into the perturbation of PPIs caused by insoluble
IIBs, we used the dataset of dysregulated D10 ATXN1-DE genes and
compared it to a cerebellum-specific human PPI network, using HIPPIE
v2.0 [37]. This database collects interactions between human proteins
scored according to the reliability of the associated experimental evi-
dence. High-confidence interactions (HIPPIE score ≥ 0.63) were con-
sidered between the products of the D10 versus D0 ATXN1-DE genes
that were expressed in the cerebellum [37], the most affected tissue in
SCA1 disorder [53]. The resulting network was formed by 516 gene
products.
Importantly, the subnetwork containing the largest connected
component (LCC) of the constructed PPI network had a statistically
significant LCC size (p-value = 8.03 × 10−4, 328 proteins,
Supplementary Table 8) when compared to a randomly sampled control
network (Fig. 6A). This strategy identified a highly interconnected PPI
module that was perturbed by the dysregulation of gene expression and
induced by the accumulation of insoluble polyQ IIBs in cells. Most of
the proteins in the LCC are down-regulated and their functional en-
richment analysis points to the perturbation of key proteins required for
proper ribosome assembly and translation (Fig. 6B–C). The most den-
sely connected region of the LCC is formed, almost entirely, by ribo-
somal subunits whose protein levels are significantly reduced in D10
MSCs containing insoluble IIBs (Table 4 and Supplementary Table 9).
Also, a significant fraction of the proteins identified in polyQ inclusions
(Supplementary Table 1) is also part of the LCC (n = 33, p-
value < 2 × 10−16), further supporting the role of IIBs in the dis-
ruption of nucleolus-related functions. Intriguingly, this network also
contains 109 human SCA1-DE components (p-value < 2 × 10−16,
Fig. 6C and Supplementary Table 8), indicating their potential re-
levance for SCA1 pathogenesis. Thus, these data support the hypothesis
that the pathogenic effect of the mutant ATXN1 in our cell model is
associated with the trapping of key protein synthesis factors and their
interactors by the polyQ IIBs.
4. Discussion
4.1. Inducible, Sleeping Beauty transposon-based expression of
ATXN1(Q82) in human MSCs
Cellular protein aggregation models are invaluable to elucidate the
pathogenic effects of polyQ IIBs in neurodegenerative diseases, in-
cluding SCA1. These models are also important for screening assays and
for drug development [13]. SCA1 patient-derived iPSCs [54], differ-
entiated into cerebellar neurons [55] provide an opportunity for
studying disease progression in the exact match of the affected cell type.
Nevertheless, the developmental reset occurring upon iPSC derivation
erases aging-associated signatures [56], which may interfere with the
aggregation process occurring in adult neurons. In fact, in the context of
Table 2
Pathway enrichment analysis of up- or down-regulated genes in Tet-On YFP-ATXN1(Q82) MSCs containing polyQ IIBs.
A. D2 versus D0
Up-regulated Down-regulated
Enrichment term Overlap p-value Enrichment term Overlap p-value
ECM-receptor interaction_hsa04512 12/82 >0.0001 Ribosome_hsa03010 30/137 >0.0001
Focal adhesion_hsa04510 16/202 >0.0001 DNA replication_hsa03030 6/36 >0.0001
PI3K-Akt signaling pathway_hsa04151 18/341 >0.0001 Alzheimer's disease_hsa05010 10/168 0.0010
Proteoglycans in cancer_hsa05205 13/203 >0.0001 Cell cycle_hsa04110 8/124 0.0018
Rap1 signaling pathway_hsa04015 13/211 >0.0001 Oxidative phosphorylation_hsa00190 8/133 0.0028
Regulation of actin cytoskeleton_hsa04810 12/214 >0.0001 Huntington's disease_hsa05016 9/193 0.0084
B. D10 versus D2
Up-regulated Down-regulated
Enrichment term Overlap p-value Enrichment term Overlap p-value
Protein digestion and absorption_hsa04974 7/90 0.0001 DNA replication_hsa03030 4/36 0.0003
AGE-RAGE signaling pathway in diabetic complications_hsa04933 6/101 0.0008 Cell cycle_hsa04110 7/124 0.0002
PI3K-Akt signaling pathway_hsa04151 9/341 0.0114 p53 signaling pathway_hsa04115 5/69 0.0004
p53 signaling pathway_hsa04115 4/69 0.0064 Axon guidance_hsa04360 6/127 0.0012
Lysosome_hsa04142 5/123 0.0104 Wnt signaling pathway_hsa04310 6/142 0.0020
Transcriptional misregulation in cancer_hsa05202 6/180 0.0131 MAPK signaling pathway_hsa04010 7/255 0.0095
Statistically significant enriched pathway terms for up- or down-regulated genes in the relevant comparisons (A. D2 versus D0 and B. D10 versus D2) and the overlap
with the components of the pathway. The analysis was performed using the KEGG database.
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Huntington's disease, protein aggregation could be detected in neurons
directly derived from fibroblasts but not in neurons differentiated from
iPSCs [57]. In line with these findings, we observed that iPSC-derived
NPCs efficiently removed small inclusions and failed to support long-
term production of the pathogenic ATXN1.
As an alternative approach, our inducible polyQ-expanded ATXN1-
based model generates reproducibly large nuclear inclusions in human
MSCs. This model overexpresses the full-length ATXN1(Q82), harboring
all domains that affect protein dimerization and aggregation [58,59] in
an inducible manner, using the Tet-On SB transposon system. The SB
system is suitable for the modification of human stem cells with high
reproducibility [60–62]. In combination with the hyperactive transpo-
sase SB100X [15], our Gateway-compatible system [63] can be used for
rapid and highly efficient generation of expression vectors. The in-
ducible expression system is not leaky and provides a tight control. It is
also suitable for a stable, forced expression of pathogenic transgenes
and a reproducible formation of the nuclear IIBs in cultured primary
human cells.
Even though MSCs are adult stem cells of mesodermal origin [64]
with a limited neurogenic differentiation potential [65], they have
several advantages compared to immortalized laboratory lines pre-
viously utilized to study polyQ protein aggregation [9,66]. These cells
can be modified using the SB system and cultured in cost-effective
conditions [17,18]. More importantly, MSCs are resistant to the pro-
teotoxic insults of ATXN1(Q82), which allowed a detailed investigation
of the gradual accumulation of the toxic protein. Also, MSCs are sub-
jected to replicative senescence, a phenomenon that resembles aging
[67] and promotes polyQ protein aggregation. Thus, MSCs proved to be
a proper choice in our studies aiming at characterizing the IIB forma-
tion of the pathogenic ATXN1.
4.2. ATXN1(Q82) gradually forms insoluble IIBs in MSCs
Prolonged induction of MSCs resulted in the formation of partially
insoluble IIBs. Using AFM, we established a set of methods to efficiently
measure nuclear coverage, determine topology of IIBs and quantify cell
stiffness in non-stained cells at different stages of their formation. In our
cell model, purified annular IIBs exhibit a significantly lower stiffness
compared to polyQ aggregates prepared in vitro [68,69], suggesting that
they contain a decreased amount of amyloid fibrils. However, the an-
nular structure might be a common feature of insoluble IIBs. Such in-
clusions have been observed in cell-free systems and transgenic mouse
models of polyQ diseases [70,71], indicating that they are polyQ
length-dependent and are specifically induced by the pathogenic pro-
tein.
Accumulation of the pathogenic ATXN1 was accompanied by dis-
crete changes in the expression profiles of nuclear proteins. This ob-
servation is consistent with the topology of IIBs. Importantly, our in-
ducible ATXN1(Q82) MSCs are suitable to model both the early and late
stage effects of protein aggregation (D2 vs D10). For example, com-
ponents of the focal adhesion complex were up-regulated at the early
stage [e.g. D2 ATXN1(Q82) MSCs], genes of the PI3K-Akt pathway were
constantly up in D2-D10, while members of the p53 signaling pathway
specifically featured in the late stage.
Table 3
Pathway enrichment analysis of down- and up-regulated genes in human SCA1 cerebellum and D10 Tet-On YFP-ATXN1(Q82) MSCs.
A. Down-regulated
SCA1 patient versus control D10 versus D0 cells
Enrichment term Overlap p-value Enrichment term Overlap p-value
Protein processing in endoplasmic reticulum_hsa04141 66/169 >0.0001 Ribosome_hsa03010 32/137 >0.0001
Spliceosome_hsa03040 52/134 >0.0001 Huntington's disease_hsa05016 12/193 0.0008
RNA degradation_hsa03018 31/77 >0.0001 DNA replication_hsa03030 5/36 0.0009
Cell cycle_hsa04110 41/124 >0.0001 Cell cycle_hsa04110 9/124 0.0012
RNA transport_hsa03013 52/172 >0.0001 Alzheimer's disease_hsa05010 10/168 0.0029
Proteasome_hsa03050 20/44 >0.0001 Parkinson's disease_hsa05012 9/142 0.0030
Protein export_hsa03060 13/23 >0.0001 Non-alcoholic fatty liver disease (NAFLD)_hsa04932 9/151 0.0045
Ubiquitin mediated proteolysis_hsa04120 42/137 >0.0001 Oxidative phosphorylation_hsa00190 8/133 0.0069
FoxO signaling pathway_hsa04068 40/133 >0.0001 Nucleotide excision repair_hsa03420 4/47 0.0165
DNA replication_hsa03030 15/36 0.0002 Spliceosome_hsa03040 7/134 0.0227
Non-homologous end-joining_hsa03450 8/13 0.0003 Pyrimidine metabolism_hsa00240 6/105 0.0229
mRNA surveillance pathway_hsa03015 28/91 0.0003 Ubiquitin mediated proteolysis_hsa04120 7/137 0.0252
Nucleotide excision repair_hsa03420 16/47 0.0018 RNA transport_hsa03013 8/172 0.0285
Oxidative phosphorylation_hsa00190 34/133 0.0029 Fatty acid biosynthesis_hsa00061 2/13 0.029
Ribosome_hsa03010 34/137 0.0049 Base excision repair_hsa03410 3/33 0.0311
B. Up-regulated
SCA1 patient versus control D10 versus D0 cells
Enrichment term Overlap p-value Enrichment term Overlap p-value
Focal adhesion_hsa04510 20/202 >0.0001 Focal adhesion_hsa04510 17/202 >0.0001
Chronic myeloid leukemia_hsa05220 11/73 0.0001 ECM-receptor interaction_hsa04512 11/82 >0.0001
Hippo signaling pathway_hsa04390 16/153 0.0001 PI3K-Akt signaling pathway_hsa04151 17/341 >0.0001
Cell adhesion molecules (CAMs)_hsa04514 15/142 0.0002 Proteoglycans in cancer_hsa05205 11/203 >0.0001
Notch signaling pathway_hsa04330 8/48 0.0003 Protein digestion and absorption_hsa04974 8/90 >0.0001
AGE-RAGE signaling pathway in diabetic
complications_hsa04933
11/101 0.0011 Regulation of actin cytoskeleton_hsa04810 11/214 0.0002
Proteoglycans in cancer_hsa05205 17/203 0.0012 Pathways in cancer_hsa05200 15/397 0.0003
Regulation of actin cytoskeleton_hsa04810 17/214 0.0021 Rap1 signaling pathway_hsa04015 10/211 0.0006
Long-term potentiation_hsa04720 8/66 0.0025 Phagosome_hsa04145 7/154 0.0049
ECM-receptor interaction_hsa04512 9/82 0.0028 Leukocyte transendothelial migration_hsa04670 6/118 0.0053
Inositol phosphate metabolism_hsa00562 8/71 0.0040 Glioma_hsa05214 4/65 0.0114
ErbB signaling pathway_hsa04012 9/87 0.0042 AGE-RAGE signaling pathway in diabetic
complications_hsa04933
5/101 0.0118
The table shows statistically significant enriched pathway terms for A. down- or B. up-regulated genes in the relevant comparisons and the overlap with the
components of the pathway. The analysis was performed using the KEGG database.
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The downregulation of genes participating in oxidative phosphor-
ylation may cause defects in the respiratory chain of both the MSCs and
the cerebellar cells of the SCA1 patient. These defects may be re-
sponsible for the cellular oxidative stress while the activation of pro-
teasome can be considered as a secondary line of defense against it. Our
findings are consistent with the stimulation of ROS production by ag-
gregating polyQ-expanded proteins [5,72] and connect to early hy-
potheses implicating oxidative stress in the pathology of neurodegen-
erative diseases [73].
The accumulation of IIBs also interferes with the nucleolus, sug-
gesting that MSCs undergo nucleolar stress [74] and eventually enter a
growth-arrest phase. This hypothesis is consistent with the down-reg-
ulation of genes involved in DNA replication and cell cycle, generally
observed here and in models of polyQ diseases [75]. In fact, proteins
oligomers were shown to dysregulate the cell cycle through the PI3K-
Akt pathway [76] which promotes necrotic cell death [77].
4.3. PolyQ-induced stress perturbs the protein synthesis machinery
PolyQ tracts are normally present in a significant percentage of
human proteins. Experimental evidence suggests that these domains
mediate PPIs during the assembly of protein complexes [78]. Patho-
genic polyQ proteins are enriched in coiled-coils [22,79] and sponta-
neously self-assemble into insoluble β-sheet rich inclusions [59,80]
which are cytotoxic when they are transported into the nucleus [81].
The enrichment of aggregated ATXN1(Q82) in coiled-coils and β-sheets,
suggests that insoluble IIBs might act as scaffolds for the sequestration
of various protein molecules, perturbing protein interaction networks.
The recruitment of ribosomal proteins and nucleophosmin, a nucleolar-
stress marker which is critical for ribosome biogenesis [82] in insoluble
IIBs indicates that these proteins are not able to perform their normal
functions. In parallel, the down-regulation of ribosomal gene expression
depletes the available ribosomal proteins in cells containing insoluble
IIBs. Our results indicate a perturbed cerebellum-specific PPI network,
which contains a densely connected subnetwork formed by components
Fig. 6. ATXN1 IIBs dysregulate ribosome assembly and translation-associated protein interactions. (A) ATXN1-DE genes significantly dysregulated between D10 and
D0 cells form a highly interconnected PPI network module (largest connected component or LCC) whose size (black arrow) is significantly greater than expected by
chance. (B) The down-regulated members of this LCC play important roles in ribosome assembly and translation. By contrast, the up-regulated members of the LCC
are involved in cellular organization functions and compartments. (C) The LCC of the constructed cerebellum-specific PPI network has a densely connected region
formed almost entirely by ribosomal subunits and contains a significant number of proteins detected by MS in the insoluble IIBs at D10 (n = 33, p-value < 0.001).
This depiction also highlights the interaction partners of ATXN1 in the LCC and human SCA1-DE genes (n = 109, p-value < 0.001, magenta color). Expression levels
of each gene in the disease cell model are also shown. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of
this article.)
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involved in RNA metabolism and protein synthesis.
Even though polyQ diseases may not share the same pathology at
early stages, perturbation of the ribosomal complex might be a common
feature at a later stage. PolyQ oligomers recruit ribosomal proteins
[4,47] and promote the cytosolic mislocalization of fibrillarin (Fbl), a
nucleolar protein involved in rRNA processing [47]. The combination
of these events results in the retention of ribosomal proteins in the
nucleus and prevents proper ribosome biogenesis. Furthermore, nu-
cleolar stress induced by pathogenic misfolded proteins results in the
extensive oxidation of ribosomal RNA, the reduction of ribosomes and
the decrease in protein synthesis [reviewed in Ref. [74]]. Eventually,
insoluble polyQ inclusions may cause similar mechanical and molecular
defects in cells containing them.
We propose a series of events induced by the pathogenic ATXN1,
including (a) down-regulation of ribosomal genes; (b) gradual induc-
tion of oxidative and nucleolar stress by expanding IIBs; and (c) se-
questration of ribosomal proteins into insoluble IIBs. Altogether, these
events cause defects in RNA metabolism, ribosome assembly and pro-
tein synthesis leading to cell necrosis (Fig. 7). Notably, our findings
correlate with the effects of the glutamine-rich PQN-41C protein in C.
elegans. PQN-41C forms non-toxic cytoplasmic aggregates and controls
non-apoptotic developmental cell death [83], supporting the hypothesis
that similar mechanisms might be activated by polyQ-expanded pro-
teins in vertebrates. Furthermore, the disturbed PPI network presented
here, contains a significant number of genes that are dysregulated in
human SCA1 cerebellum. Experimental data indicate that disrupted
homeostasis of ribosomes triggers dendritic degeneration and dis-
connection of neuronal circuitries [84]. In the long-term, perturbation
of the protein synthesis machinery may cause dysfunction of cerebellar
neurons driving them towards a necrotic state in SCA1.
5. Conclusions
Our study establishes a nuclear aggregation model of pathogenic
ATXN1, the causative mutation of the SCA1 disease. Using an inducible
SB-based expression system in MSCs, we generated primary human cells
gradually accumulating insoluble IIBs. We show that IIBs generate
cellular oxidative stress and characterized their structure and mor-
phology. Furthermore, we identified the transcriptional changes
induced by the presence of polyQ-expanded ATXN1, which are partially
observed in end-stage SCA1 cerebellum, as well. The transcriptional
changes in senescent cells containing insoluble IIBs indicate a cere-
bellum-specific perturbed protein interaction network involved in
protein synthesis. Our model can be utilized for detailed investigations
of the biochemical pathways affecting polyQ protein aggregation and
the development of protective approaches against it.
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